Neuropsychological correlates of amyloid precursor protein in Alzheimer's disease.

Full Abstract

The comprehensive cognitive screens for dementia, the Cambridge Cognitive screen (CAMCOG) and the Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) were used for assessing use of the putative Alzheimer's disease biological marker, plasma amyloid precursor protein (APP), in Alzheimer's disease and Down syndrome. The analysis suggested that there were significant correlations between amyloid precursor protein and cognitive decline as assessed by the IQCODE. Preliminary investigations of Down syndrome suggest amyloid precursor protein levels are associated with duration of dementia in the group. The findings imply circulating amyloid precursor protein has a more central role in the pathogenesis of Alzheimer's disease.

Author information

Author/s: Thomas, L D (LD);

Affiliation: Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. lthomas(-atsign-)science.canberra.edu.au

Journal and publication information

Publication Type: Journal Article

Journal: International journal of nursing practice (Int J Nurs Pract), published in AUSTRALIA. (Language: eng)

Reference: 1996-Mar; vol 2 (issue 1) : pp 29-32

Dates: Created 1997/10/02; Completed 1997/10/02; Revised 2004/11/17;

PMID: 9305029, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.